BioNano Genomics Inc
BioNano Genomics Inc logo
BNGO

BioNano Genomics Inc (BNGO)

$2.038.56%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$2.03
Day's Range
$2.22
$1.16
52-Week Range
$4.35
1 month return2.63%
3 month return8.83%
1 year return43.51%
5 year return68.24%

Company Information

Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano's Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano provides genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns.
OrganizationBioNano Genomics Inc
Employees299
CEODr. Robert Erik Holmlin M.B.A., Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 4 analysts ratings

Buy
75%
Buy
25%
Hold
0%
Sell

Based on 4 Wall street analysts offering stock ratings for BioNano Genomics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 327.09%

Current

$2.03

Target

$8.67

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
3
8
8
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
668.1M
Book Value
$0.95
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-0.33
Wall Street Target Price
8.67

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.6
Enterprise Value
498.3M
Enterprise Value/Revenue
19.25
Enterprise Value/Ebitda
-4.36

Technicals

Beta
2.26
50 Day MA
2.19
200 Day MA
2.05

Institutional Holdings

Vanguard Group Inc

5.27%

State Street Corporation

2.83%

Geode Capital Management, LLC

1.74%

Renaissance Technologies Corp

1.23%

Northern Trust Corp

0.89%

Charles Schwab Investment Management Inc

0.7%

Discover more

Frequently Asked Questions

What is BioNano Genomics Inc share price today?

Can Indians buy BioNano Genomics Inc shares?

How can I buy BioNano Genomics Inc shares from India?

Can Fractional shares of BioNano Genomics Inc be purchased?

What are the documents required to start investing in BioNano Genomics Inc stocks?

What are today’s High and Low prices of BioNano Genomics Inc?

What are today’s traded volumes of BioNano Genomics Inc?

What is today’s market capitalisation of BioNano Genomics Inc?

What is the 52 Week High and Low Range of BioNano Genomics Inc?

How much percentage BioNano Genomics Inc is down from its 52 Week High?

How much percentage BioNano Genomics Inc is up from its 52 Week low?

What are the historical returns of BioNano Genomics Inc?

Who is the Chief Executive Officer (CEO) of BioNano Genomics Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*